Replies to post #97567 on Biotech Values

[DewDiligence]

The BVF-VRX deal does not have any premium for VRX shareholders; to the contrary, the nominal buyout price of $42.77 ($16.77 in cash + $26.00 in BVF stock) is a 7% discount to VRX’s $45.87 closing price on Friday.

[DewDiligence]

Biovail completes acquisition of Valeant, assuming Valeant’s name and VRX ticker symbol:

http://finance.yahoo.com/news/Valeant-and-Biovail-Complete-prnews-3045624835.html?x=0&.v=1